154 related articles for article (PubMed ID: 29580671)
1. Intron-retained transcripts of the spinal muscular atrophy genes, SMN1 and SMN2.
Harahap NIF; Niba ETE; Ar Rochmah M; Wijaya YOS; Saito T; Saito K; Awano H; Morioka I; Iijima K; Lai PS; Matsuo M; Nishio H; Shinohara M
Brain Dev; 2018 Sep; 40(8):670-677. PubMed ID: 29580671
[TBL] [Abstract][Full Text] [Related]
2. Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing.
Dai M; Xu Y; Sun Y; Xiao B; Ying X; Liu Y; Jiang W; Zhang J; Liu X; Ji X
Mol Genet Genomics; 2022 Jul; 297(4):1039-1048. PubMed ID: 35612622
[TBL] [Abstract][Full Text] [Related]
3. The SMN1 common variant c.22 dupA in Chinese patients causes spinal muscular atrophy by nonsense-mediated mRNA decay in humans.
Bai J; Qu Y; Cao Y; Yang L; Ge L; Jin Y; Wang H; Song F
Gene; 2018 Feb; 644():49-55. PubMed ID: 29080838
[TBL] [Abstract][Full Text] [Related]
4. p.Val19Glyfs*21 and p.Leu228* variants in the survival of motor neuron 1 trigger nonsense-mediated mRNA decay causing the SMN1 PTC+ transcripts degradation.
Qu YJ; Ge L; Bai JL; Cao YY; Jin YW; Wang H; Yang L; Song F
Mutat Res; 2017 Dec; 806():31-38. PubMed ID: 28950212
[TBL] [Abstract][Full Text] [Related]
5. Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.
Brichta L; Garbes L; Jedrzejowska M; Grellscheid SN; Holker I; Zimmermann K; Wirth B
Hum Genet; 2008 Mar; 123(2):141-53. PubMed ID: 18172693
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model.
Singh NN; Singh RN
RNA Biol; 2011; 8(4):600-6. PubMed ID: 21654213
[TBL] [Abstract][Full Text] [Related]
7. Optimization of SMN trans-splicing through the analysis of SMN introns.
Shababi M; Lorson CL
J Mol Neurosci; 2012 Mar; 46(3):459-69. PubMed ID: 21826391
[TBL] [Abstract][Full Text] [Related]
8. A super minigene with a short promoter and truncated introns recapitulates essential features of transcription and splicing regulation of the SMN1 and SMN2 genes.
Ottesen EW; Seo J; Luo D; Singh NN; Singh RN
Nucleic Acids Res; 2024 Apr; 52(7):3547-3571. PubMed ID: 38214229
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
Liu H; Shafey D; Moores JN; Kothary R
J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
[TBL] [Abstract][Full Text] [Related]
10. A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy.
Wu X; Wang SH; Sun J; Krainer AR; Hua Y; Prior TW
Hum Mol Genet; 2017 Jul; 26(14):2768-2780. PubMed ID: 28460014
[TBL] [Abstract][Full Text] [Related]
11. c.835-5T>G Variant in SMN1 Gene Causes Transcript Exclusion of Exon 7 and Spinal Muscular Atrophy.
Wu S; Li YL; Cheng NY; Wang C; Dong EL; Lu YQ; Li JJ; Guo XX; Lin X; Lai LL; Liu ZW; Wang N; Chen WJ
J Mol Neurosci; 2018 Jun; 65(2):196-202. PubMed ID: 29799103
[TBL] [Abstract][Full Text] [Related]
12. SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.
Jangi M; Fleet C; Cullen P; Gupta SV; Mekhoubad S; Chiao E; Allaire N; Bennett CF; Rigo F; Krainer AR; Hurt JA; Carulli JP; Staropoli JF
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2347-E2356. PubMed ID: 28270613
[TBL] [Abstract][Full Text] [Related]
13. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
[TBL] [Abstract][Full Text] [Related]
14. A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein.
Seo J; Singh NN; Ottesen EW; Lee BM; Singh RN
Sci Rep; 2016 Aug; 6():30778. PubMed ID: 27481219
[TBL] [Abstract][Full Text] [Related]
15. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
Riessland M; Brichta L; Hahnen E; Wirth B
Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
Tiziano FD; Lomastro R; Abiusi E; Pasanisi MB; Di Pietro L; Fiori S; Baranello G; Angelini C; Sorarù G; Gaiani A; Mongini T; Vercelli L; Mercuri E; Vasco G; Pane M; Vita G; Vita G; Messina S; Petillo R; Passamano L; Politano L; Campanella A; Mantegazza R; Morandi L
J Med Genet; 2019 May; 56(5):293-300. PubMed ID: 30593463
[TBL] [Abstract][Full Text] [Related]
17. Using mini-genes to identify factors that modulate alternative splicing.
Morse R; Todd AG; Young PJ
Methods Mol Biol; 2012; 867():349-62. PubMed ID: 22454072
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
[TBL] [Abstract][Full Text] [Related]
19. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
[TBL] [Abstract][Full Text] [Related]
20. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
